Option Care Health’s (OPCH) “Market Outperform” Rating Reiterated at JMP Securities

JMP Securities restated their market outperform rating on shares of Option Care Health (NASDAQ:OPCH) in a research report sent to investors on Friday,Benzinga reports. The firm currently has a $30.00 price target on the stock, down from their previous price target of $31.00.

A number of other analysts have also weighed in on OPCH. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Barrington Research reduced their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Truist Financial reduced their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Finally, UBS Group began coverage on Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target on the stock. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $29.14.

Option Care Health Stock Down 0.6 %

Option Care Health stock opened at $23.99 on Friday. The business has a fifty day moving average of $23.10 and a two-hundred day moving average of $27.69. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market cap of $4.08 billion, a P/E ratio of 20.16, a P/E/G ratio of 2.43 and a beta of 1.31. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.63.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the business’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is owned by insiders.

Institutional Investors Weigh In On Option Care Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. UMB Bank n.a. grew its position in Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC grew its position in Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. grew its position in Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the period. International Assets Investment Management LLC grew its position in Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares during the period. Finally, Quarry LP grew its position in Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after purchasing an additional 2,628 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.